Centella AI Therapeutics
AI‑driven drug discovery platform targeting oncology and immunology, accelerating lead generation and optimization.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
AI‑driven drug discovery platform targeting oncology and immunology, accelerating lead generation and optimization.
OncologyImmunology
Technology Platform
Generative AI platform that integrates protein‑structure embeddings, multi‑omics data, and constraint‑aware molecule generation to design drug‑like compounds.
Opportunities
Expanding AI‑driven design services to global pharma partners and leveraging cost‑effective Indian R&D infrastructure for rapid pre‑clinical validation.
Risk Factors
Reliance on AI model accuracy and experimental turnaround; competitive pressure from well‑funded AI biotech firms; regulatory uncertainties for AI‑generated candidates.
Competitive Landscape
Competes with Insilico Medicine, Exscientia, and Relay Therapeutics; differentiates through constraint‑aware generative chemistry and integrated multi‑omics pipelines.